A 2026 fMRI meta-analysis of 11 studies found a narrow anxious-depression signal: 829 anxious-depression patients differed from 681 non-anxious MDD patients in left middle temporal gyrus activation (SDM-Z = 2.046, p = 0.020), while healthy-control contrasts centered on the anterior commissure and right middle frontal gyrus. The calibrated interpretation is not “amygdala and insula hyperactivity …
Travivo (Gepirone ER) is a pharmaceutical medication of the “azapirone” classification exhibiting a combination of anxiolytic, antidepressant, and libido-enhancing properties, similar to the drug Buspar (Buspirone). It was originally synthesized in 1986 by the company Bristol-Myers Squibb, and its licensing rights were acquired by the company Fabre-Kramer in 1993. In 1998, Fabre-Kramer out-licensed Gepirone to …
Buspar (Buspirone) is a drug of the azapirone chemical classification that was engineered and patented in the 1970s by Mead Johnson. It was later acquired by the pharmaceutical company Bristol-Myers Squibb and approved by the FDA in 1986 for the treatment of generalized anxiety disorder (GAD). What’s unique about buspirone compared to other anxiolytics such …